{"id":"W2160137787","doi":"10.1093/neuonc/nop015","title":"A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy","year":2009,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":298,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Cancer Institute","keywords":"Erlotinib; Medicine; Rash; Glioma; Internal medicine; Epidermal growth factor receptor; Oncology; Anaplastic astrocytoma; Erlotinib Hydrochloride; Gastroenterology; Cancer research; Cancer; Astrocytoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001126056,0.001566374,0.001924452,0.0003844656,0.000306935,0.0007383733,0.0007935786,0.001057052,0.002596021],"category_scores_gemma":[0.0007051387,0.0004347677,0.0009580234,0.0004013774,0.0006341424,0.0006395714,0.000292356,0.001976487,0.0007680748],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006377575,"about_ca_system_score_gemma":0.0009328764,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009824346,"about_ca_topic_score_gemma":0.003092047,"domain_scores_codex":[0.9996741,0.0001552883,0.00001848114,0.00004665633,0.00002359074,0.00008195066],"domain_scores_gemma":[0.9995137,0.00007120871,0.00009911784,0.00004208067,0.00003003134,0.000243754],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8467773,0.03185,0.005419678,0.0008282086,0.001193934,0.0004823059,0.0003223468,0.001743989,0.02354183,0.0003036876,0.003184837,0.08435196],"study_design_scores_gemma":[0.6962872,0.2873013,0.01040533,0.00002901643,0.000334038,0.0004790394,0.00006842126,0.001276706,0.001671494,0.0001714406,0.001948517,0.00002748074],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951817,0.001378315,0.000297252,0.0002772919,0.00007853172,0.00134328,0.0003934075,0.00007976979,0.0009703503],"genre_scores_gemma":[0.9917754,0.001432728,0.0008721611,0.0005295643,0.0001220362,0.002001002,0.001268458,0.00001927187,0.00197935],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002596021,"threshold_uncertainty_score":0.008684576,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01601057918713706,"score_gpt":0.3083108920151955,"score_spread":0.2923003128280585,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}